7 results about "Angelicae sinensis extract" patented technology

The invention relates to the technical field of cosmetics, in particular to a nanoscale repair composition, a nanoscale repair cosmetic and a preparation method and application of the nanoscale repair composition and the nanoscale repair cosmetic. The invention discloses a nanoscale repairing composition. The traditional Chinese medicine composition is prepared from the following raw material components in parts by weight: 4 to 6 parts of herba centellae extract, 2 to 4 parts of chamomile extract, 2 to 4 parts of radix ginseng extract, 1 to 3 parts of rhizoma curcumae longae extract, 3 to 5 parts of aloe extract, 1 to 3 parts of oat extract, 1 to 2 parts of liquorice root extract, 0.3 to 0.7 part of green tea extract, 0.5 to 1.5 parts of radix salviae miltiorrhizae extract, 0.5 to 1.5 parts of radix angelicae sinensis extract and 0.5 to 1.5 parts of ganoderma atrum extract. , 0.5 to 1.5 parts of radix astragali seu hedysari extract, 0.3 to 0.7 part of rhizoma polygoni cuspidati extract, and 0.3 to 0.7 part of onion extract. The nanoscale repairing composition and the nanoscale repairing cosmetic disclosed by the invention can improve the moisture content of skin, reduce moisture loss and redness of the skin, accelerate healing of injured skin, effectively relieve inflammatory response and promote collagen regeneration of the skin.

The invention discloses a skin depression repair injection and a use method thereof, and relates to the technical field of skin repair. The radix angelicae sinensis extract can achieve the effects of expanding blood vessels and improving blood circulation after being used, the radix sophorae flavescentis extract contains various antioxidants and can prevent free radicals from damaging skin cells and protect skin health, and radix angelicae sinensis and radix sophorae flavescentis are good in safety and free of toxic and side effects; the poly-bis-lactic acid stimulates generation of collagen and helps to tighten a loose fascia layer, so that the facial contour is improved, glycolic acid can effectively enter the skin, stimulate cell viability, promote synthesis of elastic fibers and collagen in dermis, reduce fine lines and wrinkles, make the skin more compact and elastic, and make the skin more smooth and elastic. Components in the collagen peptide can directly permeate into the bottom layer of the skin and can be combined with surrounding tissues to stimulate the body to generate collagen and promote normal growth of skin cells, so that the collagen peptide is beneficial to assisting in repairing scars.

The invention belongs to the field of traditional Chinese medicine, and relates to a traditional Chinese medicine composition for treating xerophthalmia, a fuming and washing agent and a preparation method and application thereof, and the traditional Chinese medicine composition for treating xerophthalmia comprises the following components in parts by weight: 20-30 parts of chrysanthemum extract dry powder, 15-20 parts of wolfberry extract dry powder, 12-18 parts of radix ophiopogonis extract dry powder and 5-10 parts of radix polygonati officinalis extract dry powder. The traditional Chinese medicine composition is prepared from 10-20 parts of radix angelicae sinensis extract dry powder, 5-15 parts of radix astragali extract dry powder, 8-14 parts of radix salviae miltiorrhizae extract dry powder, 11-17 parts of radix ampelopsis extract dry powder and 10-15 parts of sedum sarmentosum extract dry powder. The invention provides a traditional Chinese medicine composition containing chrysanthemum extract dry powder, wolfberry extract dry powder, radix ophiopogonis extract dry powder, polygonatum odoratum extract dry powder, angelica sinensis extract dry powder, astragalus membranaceus extract dry powder, salvia miltiorrhiza extract dry powder, ampelopsis japonica extract dry powder and sedum sarmentosum extract dry powder. The total effective rate of the traditional Chinese medicine composition for treating xerophthalmia can reach 90% or above.

The pill comprises the following components in percentage by weight: 10-15% of a red ginseng extract, 5-10% of a ligusticum wallichii extract, 5-10% of an angelica sinensis extract, 5-10% of an astragalus membranaceus extract, 5-10% of a medlar extract, 5-10% of a liquorice extract, 5-10% of a salvia miltiorrhiza extract, 5-10% of a pericarpium citri reticulatae extract and 5-10% of a chrysanthemum extract. The pill is prepared from, by weight, 5%-10% of radix angelicae sinensis extract, 8%-12% of radix astragali seu hedysari extract, 5%-8% of fructus lycii extract, 3%-5% of radix glycyrrhizae extract, 6%-10% of radix salviae miltiorrhizae extract, 2%-5% of pericarpium citri reticulatae extract and 2%-4% of flos chrysanthemi extract, the proportion of effective components in all the extracts is optimized, and the pill activity can be enhanced, qi and blood can be regulated, and heart blood circulation can be improved. Therefore, the safety and the quality consistency of the pill are improved while the drug effect is guaranteed, the problems that the traditional Shenqi Tongmai pill is low in traditional Chinese medicinal material extraction rate, uneven in drug effect exertion and residual in harmful ingredients are solved, and the preparation method of the Shenqi Tongmai pill which is more stable in curative effect and more remarkable in drug effect is provided.

The invention discloses an external preparation suitable for people with weakness of spleen and stomach and a preparation method thereof, the external preparation comprises a traditional Chinese medicine extract composite component, and the external preparation is prepared from the following raw materials in parts by weight: maguey leaf extract; a salvia miltiorrhiza root extract; a polygonum multiflorum root extract; a ginseng root extract; an angelica root extract; a zanthoxylum fruit extract; an astragalus membranaceus root extract; an abrus herb extract; a microcos paniculata extract; and striga asiatica extract. A microbial fermentation product comprising a Thermus thermophilus fermentation product; and Leuconostoc / radish root fermentation filtrate. The transdermal enhancer comprises a ginger extract, methyl nicotinate and a pepper extract. And the auxiliary materials comprise cyclopentasiloxane, squalane, inulin, and disteardimonium hectorite. Chinese herbal medicines are combined with a modern microbial fermentation technology, and based on a percutaneous delivery system, sub-health symptoms such as unsmooth defecation, abdominal distension, abdominal cold, abdominal fat accumulation, edema and poor complexion of people with weakness of the spleen and the stomach are improved.

The invention relates to an acupoint injection composition for treating pain and a preparation and application method thereof, and belongs to the technical field of health care medicines. The acupoint injection composition for treating pain is prepared from the following components in parts by weight: 10 to 30 parts of radix angelicae sinensis extract, 10 to 30 parts of radix ginseng extract, 10 to 30 parts of herba taraxaci extract, 5 to 20 parts of cortex eucommiae extract, 10 to 30 parts of folium artemisiae argyi extract, 5 to 20 parts of oyster extract, 10 to 30 parts of rhizoma gastrodiae extract and 5 to 10 parts of composite penetrant. Wherein the formula of the composite penetrating agent comprises the following components in parts by weight: 0.5-1 part of a clove extract, 0.5-2 parts of a pepper extract and 2-9 parts of a chemical penetration enhancer; the composition prepared by the invention has the characteristics of high permeability and pain treatment.

This application discloses the use of imperatorin angelica ester in the preparation of drugs for treating and / or preventing infections caused by intracellular bacteria, relating to the field of biomedical technology. The application includes administering an effective amount of imperatorin angelica ester to inhibit the survival of the intracellular bacteria within host macrophages. Imperatorin angelica ester specifically inhibits the survival and proliferation of intracellular bacteria (such as Mycobacterium tuberculosis, Mycobacterium abscessis, and Salmonella) within cells by modulating the immune function of host macrophages, such as enhancing their bactericidal activity or altering their intracellular microenvironment. This provides a new drug candidate and strategy for treating refractory intracellular bacterial infections, and also achieves beneficial effects such as enhancing host-directed antibacterial immunity, reducing toxic side effects, and minimizing potential drug resistance.